speb/financial-data huggingface dataset:
ORMP cash_flow (annual, 2022-12-31) — Financing Cash Flow: 10779000.00
ORMP cash_flow (annual, 2022-12-31) — Free Cash Flow: -28414000.00
ORMP cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: -13000.00
ORMP income_statement (annual, 2022-12-31) — Gain On Sale Of Security: -630000.00
ORMP income_statement (annual, 2022-12-31) — General And Administrative Expense: 13811000.00
ORMP balance_sheet (annual, 2022-12-31) — Gross PPE: 1802000.00
ORMP balance_sheet (annual, 2022-12-31) — Held To Maturity Securities: 0.00
ORMP cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 100000.00
ORMP income_statement (annual, 2022-12-31) — Interest Expense: 0.00
ORMP income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 0.00
ORMP income_statement (annual, 2022-12-31) — Interest Income: 3573000.00
ORMP income_statement (annual, 2022-12-31) — Interest Income Non Operating: 3573000.00
ORMP cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 0.00
ORMP balance_sheet (annual, 2022-12-31) — Invested Capital: 151812000.00
ORMP cash_flow (annual, 2022-12-31) — Investing Cash Flow: 30211000.00
ORMP balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 2700000.00
ORMP balance_sheet (annual, 2022-12-31) — Investments And Advances: 2700000.00
ORMP cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 11500000.00
ORMP cash_flow (annual, 2022-12-31) — Issuance Of Debt: 0.00
ORMP balance_sheet (annual, 2022-12-31) — Line Of Credit: 0.00
ORMP balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 647000.00
ORMP balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 647000.00
ORMP cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 0.00
ORMP cash_flow (annual, 2022-12-31) — Long Term Debt Payments: 0.00
ORMP balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 7000.00
ORMP balance_sheet (annual, 2022-12-31) — Minority Interest: -656000.00
ORMP income_statement (annual, 2022-12-31) — Minority Interests: 1203000.00
ORMP cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 11500000.00
ORMP cash_flow (annual, 2022-12-31) — Net Foreign Currency Exchange Gain Loss: -1550000.00
ORMP income_statement (annual, 2022-12-31) — Net Income: -36561000.00
ORMP income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -36561000.00
ORMP income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -37764000.00
ORMP income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -36561000.00
ORMP income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -36561000.00
ORMP cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -37764000.00
ORMP income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -37764000.00
ORMP income_statement (annual, 2022-12-31) — Net Interest Income: 3564000.00
ORMP cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: 30681000.00
ORMP cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 0.00
ORMP cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 0.00
ORMP income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: 3564000.00
ORMP cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -783000.00
ORMP cash_flow (annual, 2022-12-31) — Net Other Investing Changes: 2000.00
ORMP balance_sheet (annual, 2022-12-31) — Net PPE: 1802000.00
ORMP cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -472000.00
ORMP cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: 0.00
ORMP balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 151812000.00
ORMP balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 4011000.00
ORMP balance_sheet (annual, 2022-12-31) — Non Current Deferred Revenue: 4000000.00
ORMP balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 11000.00
ORMP balance_sheet (annual, 2022-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 21000.00
ORMP balance_sheet (annual, 2022-12-31) — Non Current Prepaid Assets: 7000.00
ORMP income_statement (annual, 2022-12-31) — Normalized EBITDA: -36976000.00
ORMP income_statement (annual, 2022-12-31) — Normalized Income: -36063300.00
ORMP cash_flow (annual, 2022-12-31) — Operating Cash Flow: -27918000.00
ORMP cash_flow (annual, 2022-12-31) — Operating Gains Losses: -1563000.00
ORMP income_statement (annual, 2022-12-31) — Operating Income: -40598000.00
ORMP income_statement (annual, 2022-12-31) — Operating Revenue: 2703000.00
ORMP balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 39563888.00
ORMP balance_sheet (annual, 2022-12-31) — Other Current Assets: 1389000.00
ORMP income_statement (annual, 2022-12-31) — Other Gand A: 13811000.00
ORMP income_statement (annual, 2022-12-31) — Other Income Expense: -630000.00
ORMP balance_sheet (annual, 2022-12-31) — Other Investments: 0.00
ORMP cash_flow (annual, 2022-12-31) — Other Non Cash Items: 22000.00
ORMP balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 61000.00
ORMP balance_sheet (annual, 2022-12-31) — Other Properties: 1802000.00
ORMP balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 115256000.00
ORMP balance_sheet (annual, 2022-12-31) — Payables: 2176000.00
ORMP balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 4159000.00
ORMP cash_flow (annual, 2022-12-31) — Pension And Employee Benefit Expense: 0.00
ORMP income_statement (annual, 2022-12-31) — Pretax Income: -37664000.00
ORMP cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 62000.00
ORMP cash_flow (annual, 2022-12-31) — Purchase Of Investment: -154405000.00
ORMP cash_flow (annual, 2022-12-31) — Purchase Of PPE: -496000.00
ORMP income_statement (annual, 2022-12-31) — Reconciled Depreciation: 58000.00
ORMP cash_flow (annual, 2022-12-31) — Repayment Of Debt: 0.00
ORMP income_statement (annual, 2022-12-31) — Research And Development: 27639000.00
ORMP balance_sheet (annual, 2022-12-31) — Retained Earnings: -163081000.00
ORMP cash_flow (annual, 2022-12-31) — Sale Of Investment: 185086000.00
ORMP cash_flow (annual, 2022-12-31) — Sale Of PPE: 24000.00
ORMP income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 1851000.00
ORMP income_statement (annual, 2022-12-31) — Selling General And Administration: 15662000.00
ORMP balance_sheet (annual, 2022-12-31) — Share Issued: 39563888.00
ORMP cash_flow (annual, 2022-12-31) — Short Term Debt Payments: 0.00
ORMP cash_flow (annual, 2022-12-31) — Stock Based Compensation: 11509000.00
ORMP balance_sheet (annual, 2022-12-31) — Stockholders Equity: 151812000.00
ORMP balance_sheet (annual, 2022-12-31) — Tangible Book Value: 151812000.00
ORMP income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -132300.00
ORMP income_statement (annual, 2022-12-31) — Tax Provision: 100000.00
ORMP income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.21
ORMP balance_sheet (annual, 2022-12-31) — Total Assets: 161642000.00
ORMP balance_sheet (annual, 2022-12-31) — Total Capitalization: 151812000.00
ORMP balance_sheet (annual, 2022-12-31) — Total Debt: 894000.00
ORMP balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 151156000.00
ORMP income_statement (annual, 2022-12-31) — Total Expenses: 43301000.00
ORMP balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 10486000.00
ORMP balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 4533000.00
ORMP balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 4740000.00
ORMP income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -40598000.00
ORMP income_statement (annual, 2022-12-31) — Total Other Finance Cost: 9000.00
ORMP income_statement (annual, 2022-12-31) — Total Unusual Items: -630000.00
ORMP income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -630000.00
ORMP cash_flow (annual, 2022-12-31) — Unrealized Gain Loss On Investment Securities: 763000.00
ORMP balance_sheet (annual, 2022-12-31) — Working Capital: 151363000.00
ORMP income_statement (annual, 2023-12-31) — +Operating Expense: 17109000.00
ORMP income_statement (annual, 2023-12-31) — +Total Revenue: 1340000.00
ORMP balance_sheet (annual, 2023-12-31) — Accounts Payable: 551000.00
ORMP balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 320892000.00
ORMP balance_sheet (annual, 2023-12-31) — Available For Sale Securities: 54559000.00
ORMP income_statement (annual, 2023-12-31) — Basic Average Shares: 40315068.00
ORMP income_statement (annual, 2023-12-31) — Basic EPS: 0.14
ORMP cash_flow (annual, 2023-12-31) — Beginning Cash Position: 40464000.00
ORMP cash_flow (annual, 2023-12-31) — Capital Expenditure: -254000.00
ORMP balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 609000.00
ORMP balance_sheet (annual, 2023-12-31) — Capital Stock: 485000.00
ORMP balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 9055000.00
ORMP balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 162047000.00
ORMP balance_sheet (annual, 2023-12-31) — Cash Financial: 9055000.00
ORMP cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 51978000.00
ORMP cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -73038000.00
ORMP cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -10295000.00
ORMP cash_flow (annual, 2023-12-31) — Change In Account Payable: -2225000.00
ORMP cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: 2000.00
ORMP cash_flow (annual, 2023-12-31) — Change In Other Working Capital: -1325000.00
ORMP cash_flow (annual, 2023-12-31) — Change In Payable: -2225000.00
ORMP cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: -2225000.00
ORMP cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: 852000.00
ORMP cash_flow (annual, 2023-12-31) — Change In Working Capital: -2696000.00
ORMP cash_flow (annual, 2023-12-31) — Changes In Cash: -31355000.00
ORMP balance_sheet (annual, 2023-12-31) — Common Stock: 485000.00
ORMP balance_sheet (annual, 2023-12-31) — Common Stock Equity: 163821000.00
ORMP cash_flow (annual, 2023-12-31) — Common Stock Issuance: 2428000.00
ORMP cash_flow (annual, 2023-12-31) — Common Stock Payments: 0.00
ORMP balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 1058000.00
ORMP balance_sheet (annual, 2023-12-31) — Current Assets: 162584000.00
ORMP balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 267000.00
ORMP balance_sheet (annual, 2023-12-31) — Current Debt: 51013000.00
ORMP balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 51280000.00
ORMP balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 0.00
ORMP balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 0.00
ORMP balance_sheet (annual, 2023-12-31) — Current Liabilities: 53214000.00
ORMP balance_sheet (annual, 2023-12-31) — Defined Pension Benefit: 27000.00
ORMP cash_flow (annual, 2023-12-31) — Depreciation: 196000.00
ORMP cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 196000.00
ORMP cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 196000.00
ORMP income_statement (annual, 2023-12-31) — Diluted Average Shares: 40566901.00
ORMP income_statement (annual, 2023-12-31) — Diluted EPS: 0.14
ORMP income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 5525000.00
ORMP balance_sheet (annual, 2023-12-31) — Dueto Related Parties Current: 325000.00
ORMP income_statement (annual, 2023-12-31) — EBIT: 7125000.00
ORMP income_statement (annual, 2023-12-31) — EBITDA: 7321000.00
ORMP cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: -54000.00
ORMP balance_sheet (annual, 2023-12-31) — Employee Benefits: 28000.00
ORMP cash_flow (annual, 2023-12-31) — End Cash Position: 9055000.00
ORMP balance_sheet (annual, 2023-12-31) — Financial Assets: 1440000.00
ORMP cash_flow (annual, 2023-12-31) — Financing Cash Flow: 51978000.00
ORMP cash_flow (annual, 2023-12-31) — Free Cash Flow: -10549000.00
ORMP cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: 0.00
ORMP income_statement (annual, 2023-12-31) — Gain On Sale Of Security: 16268000.00
ORMP income_statement (annual, 2023-12-31) — General And Administrative Expense: 8425000.00
ORMP balance_sheet (annual, 2023-12-31) — Gross PPE: 1567000.00
ORMP cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 0.00
ORMP balance_sheet (annual, 2023-12-31) — Income Tax Payable: 0.00
ORMP income_statement (annual, 2023-12-31) — Interest Expense: 2037000.00
ORMP income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 2037000.00
ORMP income_statement (annual, 2023-12-31) — Interest Income: 8169000.00
ORMP income_statement (annual, 2023-12-31) — Interest Income Non Operating: 8169000.00
ORMP cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 574000.00
ORMP balance_sheet (annual, 2023-12-31) — Invested Capital: 214834000.00
ORMP cash_flow (annual, 2023-12-31) — Investing Cash Flow: -73038000.00
ORMP balance_sheet (annual, 2023-12-31) — Investmentin Financial Assets: 54926000.00
ORMP balance_sheet (annual, 2023-12-31) — Investments And Advances: 54926000.00
ORMP cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 2428000.00
ORMP cash_flow (annual, 2023-12-31) — Issuance Of Debt: 99550000.00
ORMP balance_sheet (annual, 2023-12-31) — Line Of Credit: 51013000.00
ORMP balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 342000.00
ORMP balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 342000.00
ORMP cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 99550000.00
ORMP cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -50000000.00
ORMP balance_sheet (annual, 2023-12-31) — Minority Interest: -928000.00
ORMP income_statement (annual, 2023-12-31) — Minority Interests: 437000.00
ORMP cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 2428000.00
ORMP balance_sheet (annual, 2023-12-31) — Net Debt: 41958000.00
ORMP cash_flow (annual, 2023-12-31) — Net Foreign Currency Exchange Gain Loss: -2172000.00
ORMP income_statement (annual, 2023-12-31) — Net Income: 5525000.00
ORMP income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 5525000.00
ORMP income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 5088000.00
ORMP income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 5525000.00
ORMP income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 5525000.00
ORMP cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 5088000.00
ORMP income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 5088000.00
ORMP income_statement (annual, 2023-12-31) — Net Interest Income: 4589000.00
ORMP cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: -72784000.00
ORMP cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 49550000.00
ORMP cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 99550000.00
ORMP income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: 4589000.00
ORMP balance_sheet (annual, 2023-12-31) — Net PPE: 1567000.00
ORMP cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -254000.00
ORMP cash_flow (annual, 2023-12-31) — Net Short Term Debt Issuance: -50000000.00
ORMP balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 163821000.00
ORMP balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 4011000.00
ORMP balance_sheet (annual, 2023-12-31) — Non Current Deferred Revenue: 4000000.00
ORMP balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 11000.00
ORMP balance_sheet (annual, 2023-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 28000.00
ORMP balance_sheet (annual, 2023-12-31) — Non Current Prepaid Assets: 7000.00
ORMP income_statement (annual, 2023-12-31) — Normalized EBITDA: -8947000.00
ORMP income_statement (annual, 2023-12-31) — Normalized Income: -10743000.00
ORMP cash_flow (annual, 2023-12-31) — Operating Cash Flow: -10295000.00
ORMP cash_flow (annual, 2023-12-31) — Operating Gains Losses: -2175000.00
ORMP income_statement (annual, 2023-12-31) — Operating Income: -15769000.00
ORMP income_statement (annual, 2023-12-31) — Operating Revenue: 1340000.00
ORMP balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 40338979.00
ORMP balance_sheet (annual, 2023-12-31) — Other Current Assets: 537000.00
ORMP income_statement (annual, 2023-12-31) — Other Gand A: 8425000.00
ORMP income_statement (annual, 2023-12-31) — Other Income Expense: 16268000.00
ORMP balance_sheet (annual, 2023-12-31) — Other Investments: 51035000.00
ORMP cash_flow (annual, 2023-12-31) — Other Non Cash Items: 1472000.00
ORMP balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 63000.00
ORMP balance_sheet (annual, 2023-12-31) — Other Properties: 1567000.00
ORMP balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 152992000.00
ORMP balance_sheet (annual, 2023-12-31) — Payables: 876000.00
ORMP balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 1934000.00
ORMP cash_flow (annual, 2023-12-31) — Pension And Employee Benefit Expense: -3000.00
ORMP income_statement (annual, 2023-12-31) — Pretax Income: 5088000.00
ORMP cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 0.00
ORMP cash_flow (annual, 2023-12-31) — Purchase Of Investment: -190919000.00
ORMP cash_flow (annual, 2023-12-31) — Purchase Of PPE: -254000.00
ORMP income_statement (annual, 2023-12-31) — Reconciled Depreciation: 196000.00
ORMP cash_flow (annual, 2023-12-31) — Repayment Of Debt: -50000000.00
ORMP cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: 0.00
ORMP income_statement (annual, 2023-12-31) — Research And Development: 8971000.00
ORMP balance_sheet (annual, 2023-12-31) — Retained Earnings: -157556000.00
ORMP cash_flow (annual, 2023-12-31) — Sale Of Investment: 118135000.00
ORMP cash_flow (annual, 2023-12-31) — Sale Of PPE: 0.00
ORMP income_statement (annual, 2023-12-31) — Selling And Marketing Expense: -287000.00
ORMP income_statement (annual, 2023-12-31) — Selling General And Administration: 8138000.00
ORMP balance_sheet (annual, 2023-12-31) — Share Issued: 40338979.00
ORMP cash_flow (annual, 2023-12-31) — Short Term Debt Payments: -50000000.00
ORMP cash_flow (annual, 2023-12-31) — Stock Based Compensation: 4212000.00
ORMP balance_sheet (annual, 2023-12-31) — Stockholders Equity: 163821000.00
ORMP balance_sheet (annual, 2023-12-31) — Tangible Book Value: 163821000.00
ORMP income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
ORMP income_statement (annual, 2023-12-31) — Tax Provision: 0.00
ORMP income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.00
ORMP balance_sheet (annual, 2023-12-31) — Total Assets: 220551000.00
ORMP balance_sheet (annual, 2023-12-31) — Total Capitalization: 163821000.00
ORMP balance_sheet (annual, 2023-12-31) — Total Debt: 51622000.00
ORMP balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 162893000.00
ORMP income_statement (annual, 2023-12-31) — Total Expenses: 17109000.00
ORMP balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 57658000.00
ORMP balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 57967000.00
ORMP balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 4444000.00
ORMP income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -15769000.00
ORMP income_statement (annual, 2023-12-31) — Total Other Finance Cost: 1543000.00
ORMP balance_sheet (annual, 2023-12-31) — Total Tax Payable: 0.00
ORMP income_statement (annual, 2023-12-31) — Total Unusual Items: 16268000.00
ORMP income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: 16268000.00
ORMP balance_sheet (annual, 2023-12-31) — Trading Securities: 367000.00
ORMP balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 0.00
ORMP cash_flow (annual, 2023-12-31) — Unrealized Gain Loss On Investment Securities: -16392000.00
ORMP balance_sheet (annual, 2023-12-31) — Working Capital: 109370000.00
ORMP income_statement (quarterly, 2024-09-30) — Basic Average Shares: 40896845.00
ORMP income_statement (quarterly, 2024-09-30) — Basic EPS: -0.48
ORMP balance_sheet (quarterly, 2024-09-30) — Cash Financial: 42104000.00
ORMP cash_flow (quarterly, 2024-09-30) — Common Stock Issuance: 0.00
ORMP cash_flow (quarterly, 2024-09-30) — Common Stock Payments: -1291000.00
ORMP income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 40896845.00
ORMP income_statement (quarterly, 2024-09-30) — Diluted EPS: -0.48
ORMP balance_sheet (quarterly, 2024-09-30) — Financial Assets: 0.00
ORMP cash_flow (quarterly, 2024-09-30) — Income Tax Paid Supplemental Data: 0.00
ORMP cash_flow (quarterly, 2024-09-30) — Issuance Of Capital Stock: 0.00
ORMP balance_sheet (quarterly, 2024-09-30) — Line Of Credit: 0.00
ORMP cash_flow (quarterly, 2024-09-30) — Long Term Debt Payments: 0.00
ORMP cash_flow (quarterly, 2024-09-30) — Net Common Stock Issuance: -1291000.00
ORMP cash_flow (quarterly, 2024-09-30) — Net Long Term Debt Issuance: 0.00
ORMP cash_flow (quarterly, 2024-09-30) — Net Short Term Debt Issuance: 0.00
ORMP balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Liabilities: 11000.00
ORMP balance_sheet (quarterly, 2024-09-30) — Other Investments: 16901000.00
ORMP cash_flow (quarterly, 2024-09-30) — Other Non Cash Items: 0.00
ORMP balance_sheet (quarterly, 2024-09-30) — Other Non Current Liabilities: 60000.00
ORMP cash_flow (quarterly, 2024-09-30) — Repurchase Of Capital Stock: -1291000.00
ORMP income_statement (quarterly, 2024-09-30) — Selling And Marketing Expense: 0.00
ORMP cash_flow (quarterly, 2024-09-30) — Short Term Debt Payments: 0.00
ORMP income_statement (quarterly, 2024-09-30) — Total Other Finance Cost: 15420000.00
ORMP income_statement (annual, 2024-12-31) — +Operating Expense: 12781000.00
ORMP income_statement (annual, 2024-12-31) — +Total Revenue: 0.00
ORMP balance_sheet (annual, 2024-12-31) — Accounts Payable: 789000.00
ORMP balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 322401000.00
ORMP balance_sheet (annual, 2024-12-31) — Available For Sale Securities: 10911000.00
ORMP income_statement (annual, 2024-12-31) — Basic Average Shares: 40850446.00
ORMP income_statement (annual, 2024-12-31) — Basic EPS: -0.48
ORMP cash_flow (annual, 2024-12-31) — Beginning Cash Position: 9055000.00
ORMP cash_flow (annual, 2024-12-31) — Capital Expenditure: -18000.00
ORMP cash_flow (quarterly, 2024-12-31) — Capital Expenditure: -11000.00
ORMP balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 372000.00
ORMP balance_sheet (annual, 2024-12-31) — Capital Stock: 480000.00
ORMP balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 54420000.00
ORMP balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 141930000.00
ORMP cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -52036000.00
ORMP cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: 105817000.00
ORMP cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -8412000.00
ORMP cash_flow (annual, 2024-12-31) — Change In Account Payable: 3525000.00
ORMP cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -14000.00
ORMP cash_flow (annual, 2024-12-31) — Change In Other Working Capital: 45000.00
ORMP cash_flow (annual, 2024-12-31) — Change In Payable: 3525000.00
ORMP cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 3525000.00
ORMP cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: -356000.00
ORMP cash_flow (annual, 2024-12-31) — Change In Working Capital: 3200000.00
ORMP cash_flow (annual, 2024-12-31) — Changes In Cash: 45369000.00
ORMP balance_sheet (annual, 2024-12-31) — Common Stock: 480000.00
ORMP balance_sheet (annual, 2024-12-31) — Common Stock Equity: 146265000.00
ORMP cash_flow (annual, 2024-12-31) — Common Stock Issuance: 0.00
ORMP cash_flow (quarterly, 2024-12-31) — Common Stock Issuance: 0.00
ORMP cash_flow (annual, 2024-12-31) — Common Stock Payments: -2484000.00
ORMP cash_flow (quarterly, 2024-12-31) — Common Stock Payments: -1193000.00
ORMP income_statement (annual, 2024-12-31) — Cost Of Revenue: 0.00
ORMP balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 1147000.00
ORMP balance_sheet (annual, 2024-12-31) — Current Assets: 143221000.00
ORMP balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 216000.00
ORMP balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 216000.00
ORMP balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 0.00
ORMP balance_sheet (quarterly, 2024-12-31) — Current Deferred Liabilities: 0.00
ORMP balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 0.00
ORMP balance_sheet (quarterly, 2024-12-31) — Current Deferred Revenue: 0.00
ORMP balance_sheet (annual, 2024-12-31) — Current Liabilities: 5685000.00
ORMP cash_flow (annual, 2024-12-31) — Deferred Income Tax: 0.00
ORMP cash_flow (annual, 2024-12-31) — Deferred Tax: 0.00
ORMP balance_sheet (annual, 2024-12-31) — Defined Pension Benefit: 32000.00
ORMP cash_flow (annual, 2024-12-31) — Depreciation: 193000.00
ORMP cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 193000.00
ORMP cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 193000.00
ORMP income_statement (annual, 2024-12-31) — Diluted Average Shares: 40850446.00
ORMP income_statement (annual, 2024-12-31) — Diluted EPS: -0.48
ORMP income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -19060000.00
ORMP balance_sheet (annual, 2024-12-31) — Dividends Payable: 0.00
ORMP balance_sheet (quarterly, 2024-12-31) — Dividends Payable: 0.00
ORMP balance_sheet (annual, 2024-12-31) — Dueto Related Parties Current: 329000.00
ORMP income_statement (annual, 2024-12-31) — EBIT: -15067000.00
ORMP income_statement (annual, 2024-12-31) — EBITDA: -14874000.00
ORMP cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -4000.00
ORMP balance_sheet (annual, 2024-12-31) — Employee Benefits: 30000.00
ORMP cash_flow (annual, 2024-12-31) — End Cash Position: 54420000.00
ORMP balance_sheet (annual, 2024-12-31) — Financial Assets: 0.00
ORMP balance_sheet (quarterly, 2024-12-31) — Financial Assets: 0.00
ORMP cash_flow (annual, 2024-12-31) — Financing Cash Flow: -52036000.00
ORMP cash_flow (annual, 2024-12-31) — Free Cash Flow: -8430000.00
ORMP income_statement (annual, 2024-12-31) — Gain On Sale Of Security: -7242000.00
ORMP income_statement (annual, 2024-12-31) — General And Administrative Expense: 6457000.00
ORMP balance_sheet (annual, 2024-12-31) — Gross PPE: 1112000.00
ORMP income_statement (annual, 2024-12-31) — Gross Profit: 0.00
ORMP balance_sheet (annual, 2024-12-31) — Income Tax Payable: 3204000.00
ORMP income_statement (annual, 2024-12-31) — Interest Expense: 853000.00
ORMP income_statement (quarterly, 2024-12-31) — Interest Expense: 0.00
ORMP income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 853000.00
ORMP income_statement (quarterly, 2024-12-31) — Interest Expense Non Operating: 0.00
ORMP income_statement (annual, 2024-12-31) — Interest Income: 4983000.00
ORMP income_statement (quarterly, 2024-12-31) — Interest Income: 1096000.00
ORMP income_statement (annual, 2024-12-31) — Interest Income Non Operating: 4983000.00
ORMP income_statement (quarterly, 2024-12-31) — Interest Income Non Operating: 1096000.00
ORMP cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 2316000.00
ORMP cash_flow (quarterly, 2024-12-31) — Interest Paid Supplemental Data: 0.00
ORMP balance_sheet (annual, 2024-12-31) — Invested Capital: 146265000.00
ORMP cash_flow (annual, 2024-12-31) — Investing Cash Flow: 105817000.00
ORMP balance_sheet (annual, 2024-12-31) — Investment Properties: 0.00
ORMP balance_sheet (quarterly, 2024-12-31) — Investment Properties: 0.00
ORMP balance_sheet (annual, 2024-12-31) — Investmentin Financial Assets: 10911000.00
ORMP balance_sheet (annual, 2024-12-31) — Investments And Advances: 10911000.00
ORMP balance_sheet (annual, 2024-12-31) — Investmentsin Associatesat Cost: 0.00
ORMP balance_sheet (quarterly, 2024-12-31) — Investmentsin Associatesat Cost: 0.00
ORMP cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 0.00
ORMP cash_flow (quarterly, 2024-12-31) — Issuance Of Capital Stock: 0.00
ORMP cash_flow (annual, 2024-12-31) — Issuance Of Debt: 0.00
ORMP cash_flow (quarterly, 2024-12-31) — Issuance Of Debt: 0.00
ORMP balance_sheet (annual, 2024-12-31) — Line Of Credit: 0.00
ORMP balance_sheet (quarterly, 2024-12-31) — Line Of Credit: 0.00
ORMP balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 156000.00
ORMP balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 156000.00
ORMP cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 0.00
ORMP balance_sheet (annual, 2024-12-31) — Long Term Equity Investment: 0.00
ORMP balance_sheet (annual, 2024-12-31) — Minority Interest: -918000.00
ORMP balance_sheet (quarterly, 2024-12-31) — Minority Interest: -918000.00
ORMP income_statement (annual, 2024-12-31) — Minority Interests: 43000.00
ORMP income_statement (quarterly, 2024-12-31) — Minority Interests: 10000.00
ORMP cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: 0.00
ORMP cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: -2484000.00
ORMP cash_flow (quarterly, 2024-12-31) — Net Common Stock Issuance: -1193000.00
ORMP cash_flow (annual, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: -2700000.00
ORMP income_statement (annual, 2024-12-31) — Net Income: -19060000.00
ORMP income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -19060000.00
ORMP income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -19103000.00
ORMP income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -19060000.00
ORMP income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -19060000.00
ORMP cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -19103000.00
ORMP income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -19103000.00
ORMP income_statement (annual, 2024-12-31) — Net Interest Income: 4103000.00
ORMP cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 105900000.00
ORMP cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -49550000.00
ORMP cash_flow (quarterly, 2024-12-31) — Net Issuance Payments Of Debt: 0.00
ORMP cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: 0.00
ORMP income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 4103000.00
ORMP cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -2000.00
ORMP cash_flow (annual, 2024-12-31) — Net Other Investing Changes: -65000.00
ORMP balance_sheet (annual, 2024-12-31) — Net PPE: 1112000.00
ORMP cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -18000.00
ORMP cash_flow (annual, 2024-12-31) — Net Short Term Debt Issuance: -49550000.00
ORMP cash_flow (quarterly, 2024-12-31) — Net Short Term Debt Issuance: 0.00
ORMP balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 146265000.00
ORMP balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 4000000.00
ORMP balance_sheet (annual, 2024-12-31) — Non Current Deferred Revenue: 4000000.00
ORMP balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 0.00
ORMP balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Taxes Liabilities: 0.00
ORMP balance_sheet (annual, 2024-12-31) — Non Current Note Receivables: 0.00
ORMP balance_sheet (annual, 2024-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 30000.00
ORMP balance_sheet (annual, 2024-12-31) — Non Current Prepaid Assets: 2000.00
ORMP income_statement (annual, 2024-12-31) — Normalized EBITDA: -7632000.00
ORMP income_statement (annual, 2024-12-31) — Normalized Income: -13338820.00
ORMP balance_sheet (annual, 2024-12-31) — Notes Receivable: 0.00
ORMP balance_sheet (quarterly, 2024-12-31) — Notes Receivable: 0.00
ORMP cash_flow (annual, 2024-12-31) — Operating Cash Flow: -8412000.00
ORMP cash_flow (annual, 2024-12-31) — Operating Gains Losses: -2705000.00
ORMP income_statement (annual, 2024-12-31) — Operating Income: -12781000.00
ORMP income_statement (annual, 2024-12-31) — Operating Revenue: 0.00
ORMP balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 39919545.00
ORMP balance_sheet (annual, 2024-12-31) — Other Current Assets: 1291000.00
ORMP income_statement (annual, 2024-12-31) — Other Gand A: 6457000.00
ORMP income_statement (annual, 2024-12-31) — Other Income Expense: -7242000.00
ORMP cash_flow (annual, 2024-12-31) — Other Non Cash Items: -1463000.00
ORMP cash_flow (quarterly, 2024-12-31) — Other Non Cash Items: 0.00
ORMP balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 60000.00
ORMP balance_sheet (quarterly, 2024-12-31) — Other Non Current Liabilities: 60000.00
ORMP balance_sheet (annual, 2024-12-31) — Other Properties: 1112000.00
ORMP balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 87510000.00
ORMP balance_sheet (annual, 2024-12-31) — Payables: 4322000.00
ORMP balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 5469000.00
ORMP cash_flow (annual, 2024-12-31) — Pension And Employee Benefit Expense: -5000.00
ORMP income_statement (annual, 2024-12-31) — Pretax Income: -15920000.00
ORMP cash_flow (annual, 2024-12-31) — Purchase Of Business: 0.00
ORMP cash_flow (annual, 2024-12-31) — Purchase Of Investment: -55757000.00
ORMP cash_flow (annual, 2024-12-31) — Purchase Of PPE: -18000.00
ORMP balance_sheet (annual, 2024-12-31) — Receivables: 0.00
ORMP balance_sheet (quarterly, 2024-12-31) — Receivables: 0.00
ORMP income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 0.00
ORMP income_statement (annual, 2024-12-31) — Reconciled Depreciation: 193000.00
ORMP cash_flow (annual, 2024-12-31) — Repayment Of Debt: -49550000.00
ORMP cash_flow (quarterly, 2024-12-31) — Repayment Of Debt: 0.00
ORMP cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -2484000.00
ORMP cash_flow (quarterly, 2024-12-31) — Repurchase Of Capital Stock: -1193000.00
ORMP income_statement (annual, 2024-12-31) — Research And Development: 6324000.00
ORMP balance_sheet (annual, 2024-12-31) — Retained Earnings: -176616000.00
ORMP cash_flow (annual, 2024-12-31) — Sale Of Investment: 161657000.00
ORMP income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 0.00
ORMP income_statement (quarterly, 2024-12-31) — Selling And Marketing Expense: 0.00
ORMP income_statement (annual, 2024-12-31) — Selling General And Administration: 6457000.00
ORMP balance_sheet (annual, 2024-12-31) — Share Issued: 39919545.00
ORMP cash_flow (annual, 2024-12-31) — Short Term Debt Payments: -49550000.00
ORMP cash_flow (quarterly, 2024-12-31) — Short Term Debt Payments: 0.00
ORMP cash_flow (annual, 2024-12-31) — Stock Based Compensation: 4053000.00
ORMP balance_sheet (annual, 2024-12-31) — Stockholders Equity: 146265000.00
ORMP balance_sheet (annual, 2024-12-31) — Tangible Book Value: 146265000.00
ORMP income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -1520820.00
ORMP income_statement (annual, 2024-12-31) — Tax Provision: 3183000.00
ORMP income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.21
ORMP balance_sheet (annual, 2024-12-31) — Total Assets: 155278000.00
ORMP balance_sheet (annual, 2024-12-31) — Total Capitalization: 146265000.00
ORMP balance_sheet (annual, 2024-12-31) — Total Debt: 372000.00
ORMP balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 145347000.00
ORMP income_statement (annual, 2024-12-31) — Total Expenses: 12781000.00
ORMP balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 9931000.00
ORMP balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 12057000.00
ORMP balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 4246000.00
ORMP income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -12781000.00
ORMP income_statement (annual, 2024-12-31) — Total Other Finance Cost: 27000.00
ORMP balance_sheet (annual, 2024-12-31) — Total Tax Payable: 3204000.00
ORMP income_statement (annual, 2024-12-31) — Total Unusual Items: -7242000.00
ORMP income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -7242000.00
ORMP balance_sheet (annual, 2024-12-31) — Trading Securities: 0.00
ORMP balance_sheet (quarterly, 2024-12-31) — Trading Securities: 0.00
ORMP cash_flow (annual, 2024-12-31) — Unrealized Gain Loss On Investment Securities: 7413000.00
ORMP balance_sheet (annual, 2024-12-31) — Working Capital: 137536000.00
ORMP income_statement (quarterly, 2025-03-31) — +Operating Expense: 4513000.00
ORMP income_statement (quarterly, 2025-03-31) — +Total Revenue: 2000000.00
ORMP balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 509000.00
ORMP balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 324579000.00
ORMP balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 8890000.00
ORMP income_statement (quarterly, 2025-03-31) — Basic Average Shares: 41228782.00
ORMP income_statement (quarterly, 2025-03-31) — Basic EPS: -0.19
ORMP cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 54420000.00
ORMP cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -3000.00
ORMP balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 301000.00
ORMP balance_sheet (quarterly, 2025-03-31) — Capital Stock: 491000.00
ORMP balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 74516000.00
ORMP balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 130644000.00
ORMP cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: 0.00
ORMP balance_sheet (quarterly, 2025-03-31) — Cash Financial: 74516000.00
ORMP cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 0.00
ORMP cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: 23616000.00
ORMP cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -3519000.00
ORMP cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -185000.00
ORMP cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -60000.00
ORMP cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: -1996000.00
ORMP cash_flow (quarterly, 2025-03-31) — Change In Payable: -185000.00
ORMP cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -185000.00
ORMP cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: 667000.00
ORMP cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -1574000.00
ORMP cash_flow (quarterly, 2025-03-31) — Changes In Cash: 20097000.00
ORMP balance_sheet (quarterly, 2025-03-31) — Common Stock: 491000.00
ORMP cash_flow (quarterly, 2025-03-31) — Common Stock Dividend Paid: 0.00
ORMP balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 140812000.00
ORMP balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 1221000.00
ORMP income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 1987000.00
ORMP balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 978000.00
ORMP balance_sheet (quarterly, 2025-03-31) — Current Assets: 131476000.00
ORMP balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 181000.00
ORMP balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 181000.00
ORMP balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 5492000.00
ORMP cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: 0.00
ORMP cash_flow (quarterly, 2025-03-31) — Deferred Tax: 0.00
ORMP balance_sheet (quarterly, 2025-03-31) — Defined Pension Benefit: 32000.00
ORMP cash_flow (quarterly, 2025-03-31) — Depreciation: 30000.00
ORMP cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 30000.00
ORMP cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 30000.00
ORMP income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 41228782.00
ORMP income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.19
ORMP income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -7642000.00
ORMP balance_sheet (quarterly, 2025-03-31) — Dueto Related Parties Current: 36000.00
ORMP income_statement (quarterly, 2025-03-31) — EBIT: -4500000.00
ORMP income_statement (quarterly, 2025-03-31) — EBITDA: -4470000.00
ORMP cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: -1000.00
ORMP balance_sheet (quarterly, 2025-03-31) — Employee Benefits: 33000.00
ORMP cash_flow (quarterly, 2025-03-31) — End Cash Position: 74516000.00
ORMP cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 0.00
ORMP cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -3522000.00
ORMP income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: -3062000.00
ORMP income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 2307000.00
ORMP balance_sheet (quarterly, 2025-03-31) — Gross PPE: 2234000.00
ORMP income_statement (quarterly, 2025-03-31) — Gross Profit: 13000.00
ORMP balance_sheet (quarterly, 2025-03-31) — Income Tax Payable: 3788000.00
ORMP income_statement (quarterly, 2025-03-31) — Interest Expense: 2558000.00
ORMP income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 2558000.00
ORMP income_statement (quarterly, 2025-03-31) — Interest Income: 647000.00
ORMP income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 647000.00
ORMP cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 0.00
ORMP balance_sheet (quarterly, 2025-03-31) — Invested Capital: 140812000.00
ORMP cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: 23616000.00
ORMP balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 8890000.00
ORMP balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 9530000.00
ORMP balance_sheet (quarterly, 2025-03-31) — Investmentsin Subsidiariesat Cost: 640000.00
ORMP balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 120000.00
ORMP balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 120000.00
ORMP cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: 0.00
ORMP balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 640000.00
ORMP balance_sheet (quarterly, 2025-03-31) — Minority Interest: -918000.00
ORMP income_statement (quarterly, 2025-03-31) — Minority Interests: 0.00
ORMP cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: -7250000.00
ORMP cash_flow (quarterly, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: 130000.00
ORMP income_statement (quarterly, 2025-03-31) — Net Income: -7642000.00
ORMP income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -7642000.00
ORMP income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -7642000.00
ORMP income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -7642000.00
ORMP income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -7642000.00
ORMP cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -7642000.00
ORMP income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -7642000.00
ORMP income_statement (quarterly, 2025-03-31) — Net Interest Income: 504000.00
ORMP cash_flow (quarterly, 2025-03-31) — Net Investment Properties Purchase And Sale: -1194000.00
ORMP cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 29327000.00
ORMP cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 0.00
ORMP cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: 0.00
ORMP income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 504000.00
ORMP cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: 2736000.00
ORMP balance_sheet (quarterly, 2025-03-31) — Net PPE: 2234000.00
ORMP cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -3000.00
ORMP balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 140812000.00
ORMP balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 2000000.00
ORMP balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 2000000.00
ORMP balance_sheet (quarterly, 2025-03-31) — Non Current Note Receivables: 4265000.00
ORMP balance_sheet (quarterly, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 33000.00
ORMP balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 2000.00
ORMP income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -1408000.00
ORMP income_statement (quarterly, 2025-03-31) — Normalized Income: -5223020.00
ORMP cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -3519000.00
ORMP cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 130000.00
ORMP income_statement (quarterly, 2025-03-31) — Operating Income: -4500000.00
ORMP income_statement (quarterly, 2025-03-31) — Operating Revenue: 2000000.00
ORMP balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 40850455.00
ORMP balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 832000.00
ORMP income_statement (quarterly, 2025-03-31) — Other Gand A: 2307000.00
ORMP income_statement (quarterly, 2025-03-31) — Other Income Expense: -3062000.00
ORMP balance_sheet (quarterly, 2025-03-31) — Other Properties: 1013000.00
ORMP balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 56128000.00
ORMP balance_sheet (quarterly, 2025-03-31) — Payables: 4333000.00
ORMP balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 5311000.00
ORMP cash_flow (quarterly, 2025-03-31) — Pension And Employee Benefit Expense: 0.00
ORMP income_statement (quarterly, 2025-03-31) — Pretax Income: -7058000.00
ORMP cash_flow (quarterly, 2025-03-31) — Purchase Of Business: -7250000.00
ORMP cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: 0.00
ORMP cash_flow (quarterly, 2025-03-31) — Purchase Of Investment Properties: -1194000.00
ORMP cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -3000.00
ORMP income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 1987000.00
ORMP income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 30000.00
ORMP cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: 0.00
ORMP income_statement (quarterly, 2025-03-31) — Research And Development: 2206000.00
ORMP balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -184258000.00
ORMP cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 29327000.00
ORMP income_statement (quarterly, 2025-03-31) — Selling General And Administration: 2307000.00
ORMP balance_sheet (quarterly, 2025-03-31) — Share Issued: 40850455.00
ORMP cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 2189000.00
ORMP balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 140812000.00
ORMP balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 140812000.00
ORMP income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -643020.00
ORMP income_statement (quarterly, 2025-03-31) — Tax Provision: 584000.00
ORMP income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.21
ORMP balance_sheet (quarterly, 2025-03-31) — Total Assets: 147539000.00
ORMP balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 140812000.00
ORMP balance_sheet (quarterly, 2025-03-31) — Total Debt: 301000.00
ORMP balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 139894000.00
ORMP income_statement (quarterly, 2025-03-31) — Total Expenses: 6500000.00
ORMP balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 7645000.00
ORMP balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 16063000.00
ORMP balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 2153000.00
ORMP income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -4500000.00
ORMP income_statement (quarterly, 2025-03-31) — Total Other Finance Cost: 143000.00
ORMP balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 3788000.00